Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

World 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2021Covering USA Europe China Japan SEA and India

  • ICR850307
  • 113 Pages
  • December 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Summary

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control).

ICRWorld’s 23-Valent Pneumococcal Polysaccharide Vaccine market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.

The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market.

The report includes the forecasts, analysis and discuion of important industry trends, market size, market share estimates and profiles of the leading industry players.

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Product Segment Analysis

Single Dose Vial

Pre-filled Syringe

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Application Segment Analysis

For Children (2-10)

For Person (10-64)

For The old (?65)

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Regional Segment Analysis

USA

Europe

Japan

China

India

South East Asia

The players mentioned in our report

MSD

Sanofipasteur

CDIBP

Table of Content

Chapter 1 About the 23-Valent Pneumococcal Polysaccharide Vaccine Industry

1.1 Industry Definition

1.1.1 Types of 23-Valent Pneumococcal Polysaccharide Vaccine industry

1.2.1.1 Single Dose Vial

1.2.1.2 Pre-filled Syringe

1.2 Main Market Activities

1.3 Similar Industries

1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape

2.1 23-Valent Pneumococcal Polysaccharide Vaccine Markets by regions

2.1.1 USA

Market Revenue by types, Through 2021

Market overview

Major players Revenue in 2015

2.1.2 Europe

Market Revenue by types, Through 2021

Market overview

Major players Revenue in 2015

2.1.3 China

Market Revenue by types, Through 2021

Market overview

Major players Revenue in 2015

2.1.4 India

Market Revenue by types, Through 2021

Market overview

Major players Revenue in 2015

2.1.5 Japan

Market Revenue by types, Through 2021

Market overview

Major players Revenue in 2015

2.1.6 South East Asia

Market Revenue by types, Through 2021

Market overview

Major players Revenue in 2015

2.2 World 23-Valent Pneumococcal Polysaccharide Vaccine Market by types

Single Dose Vial

Pre-filled Syringe

2.3 World 23-Valent Pneumococcal Polysaccharide Vaccine Market by Applications

For Children (2-10)

For Person (10-64)

For The old (?65)

Chapter 3 World 23-Valent Pneumococcal Polysaccharide Vaccine Market share

3.1 Major players Market share by production

3.2 Major players Market share by Revenue

3.3 Major Regions Market share by Production in 2015, Through 2021

3.4 Major Regions Market share By Revenue in 2015, Through 2021

Chapter 4 Supply Chain

4.1 Industry Supply chain Analysis

4.2 Raw material Market analysis

4.2.1 Raw material Prices analysis 2012-2016

4.2.2 Raw material Supply Market analysis

4.2 Manufacturing Equipment Suppliers Analysis

4.3 Production Proce Analysis

4.4 Production Cost Structure Benchmarks

4.5 End users Market Analysis

Chapter 5 Company Profiles

5.1 MSD

5.1.1 Company Details (Foundation Year, Employee Strength and etc)

5.1.2 Product Information (Picture, Specifications and Applications)

5.1.3 Revenue, Price and Operating Profits

5.2 Sanofipasteur

5.2.1 Company Details (Foundation Year, Employee Strength and etc)

5.2.2 Product Information (Picture, Specifications and Applications)

5.2.3 Revenue, Price and Operating Profits

5.10 CDIBP

5.10.1 Company Details (Foundation Year, Employee Strength and etc)

5.10.2 Product Information (Picture, Specifications and Applications)

5.10.3 Revenue, Price and Operating Profits

Chapter 6 Globalisation & Trade

6.1 Busine Locations

6.2 Supply channels

6.3 Marketing strategy

6.4 Barriers to Entry

Chapter 7 Distributors and Customers

7.1 Major Distributors and contact information by regions

7.2 Major Customers and contact information by regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries

8.1 USA

8.2 Germany

8.3 China

8.4 Japan

8.5 India

8.6 South East Asia

Chapter 9 World 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast through 2021

9.1 World 23-Valent Pneumococcal Polysaccharide Vaccine Demand by Regions Forecast through 2021

9.2 World 23-Valent Pneumococcal Polysaccharide Vaccine Price(by Regions, Types, Applications)Analysis Forecast through 2021

9.3 World 23-Valent Pneumococcal Polysaccharide Vaccine Revenue(by Regions, Types, Applications) Forecast through 2021

Chapter 10 Key succe factors and Market Overview

Tables and figures

Table Main Market Activities by Regions

Table Market Revenue by types, Through 2021

Table Major players Revenue in 2015

Table Market Revenue by types, Through 2021

Table Major players Revenue in 2015

Table Market Revenue by types, Through 2021

Table Major players Revenue in 2015

Table Market Revenue by types, Through 2021

Table Major players Revenue in 2015

Table Market Revenue by types, Through 2021

Table Major players Revenue in 2015

Table Major players Market share by production 2015

Table Major players Market share by Revenue 2015

Table Major Regions Market share by Production in 2015-2016

Table Major Regions Market share by Production in 2017-2021

Table Major Regions Market share by Revenue in 2015-2016

Table Major Regions Market share by Revenue in 2017-2021

Table Industry Supply chain Analysis

Table Raw material Prices analysis 2012-2016

Table Raw material Suppliers Market analysis

Table Manufacturing Equipment Suppliers Analysis

Figure Production Proce Analysis

Figure Production Cost Structure

Table major End Users by regions

Table MSD Information List

Figure 23-Valent Pneumococcal Polysaccharide Vaccine23-Valent Pneumococcal Polysaccharide Vaccine Picture, Specifications and Applications of MSD

Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of MSD 2015

Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Doses) and World Market Share of MSD 2015

Table Sanofipasteur Information List

Figure 23-Valent Pneumococcal Polysaccharide Vaccine Picture, Specifications and Applications of Sanofipasteur

Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofipasteur 2015

Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Doses) and World Market Share of Sanofipasteur 2015

Table CDIBP Information List

Figure 23-Valent Pneumococcal Polysaccharide Vaccine Picture, Specifications and Applications of CDIBP

Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CDIBP 2015

Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Doses) and World Market Share of CDIBP 2015

Table Busine Locations

Figure Supply channels

Figure Marketing strategy

Table Barriers Analysis to Entry

Table Major Distributors and contact information by regions

Table Major Customers and contact information by regions

Table USA Supply, Import, Export, Consumption (K Doses) and Consumption Value(M USD)

Table Germany Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)

Table China Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)

Table Japan Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)

Table India Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)

Table South East Asia Supply, Import, Export, Consumption(23-Valent Pneumococcal Polysaccharide Vaccines) and Consumption Value(M USD)

Table World Demand (K Doses) by Regions Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)

Table World Price by Regions Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)

Table World Price by Types Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)

Table World Price by Applications Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)

Table World Revenue by Regions Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)

Table World Revenue (M USD) by Types Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370